Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05328986 · ClinicalTrials.gov registry record
Kidney Disease After COVID-19
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 1,753
- Enrollment target
NCT05328986 is a clinical trial that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 1,753 participants.
The verdict
NCT05328986 has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 1,753 participants
- Enrollment target
Study Summary
To understand the long-term epidemiology, develop effective risk-prediction and stratification tools, and understand the pathobiology of kidney disease in COVID-19 survivors.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,753 participants |
| Start Date | 2020-01-04 |
| Est. Completion | 2024-01-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05328986
The ClinicalTrials.gov registry entry for NCT05328986 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,753 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05328986 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05328986 about?
NCT05328986 is a clinical study titled "Kidney Disease After COVID-19". To understand the long-term epidemiology, develop effective risk-prediction and stratification tools, and understand the pathobiology of kidney disease in COVID-19 survivors.
What is the current status of trial NCT05328986?
This trial is currently completed. The enrollment target is 1,753 participants. The study started on 2020-01-04. Estimated completion is 2024-01-04.
Who is sponsoring clinical trial NCT05328986?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.